Resources

The STIWatch resource database offers a range of material on the status of STI vaccine and diagnostics research, development and availability. 

STIWatch’s Clinical Trials Dashboard

The STI Clinical Trials Dashboard provides information about trials focused on vaccines, diagnostics, and the use of doxycycline post-exposure prophylaxis (DoxyPEP) to detect, treat, and prevent chlamydia, gonorrhea, hepatitis B, herpes simplex virus (HSV), human papillomavirus, syphilis and trichomoniasis infections.

View the Dashboard

Resource List

Regulatory Pathways to Promote Access to STI Diagnostics

Webinar Synopsis
30/10/2024

Framework for monitoring sexually transmitted infections and strengthening surveillance

Technical Document
18/07/2024

Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (‎syphilis)‎ and new recommendations on syphilis testing and partner services

Guideline
17/07/2024

Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus

Guideline
16/07/2024

Sexually Transmitted Infections (STIs)

WHO Fact Sheet
21/05/2024

Sexually Transmitted Infections: An introductory fact sheet

AVAC Fact Sheet
18/05/2023

Advocates’ Guide to Doxycycline to Prevent Bacterial STIs (DoxyPEP)

Factsheet
07/08/2024

Diagnostics Landscape for Sexually Transmitted Infections

WHO report highlighting diagnostics available to support scale-up and expanded access
20/07/2023

Point-of-Care Tests for Sexually Transmitted Infections — Target product profiles

WHO guide to facilitate development of STI diagnostics
18/07/2023

The STI Roadmap

Collaboration, coordination, communication and advocacy are essential to catalyze vaccine development action. The World Health Organization, the US National Institutes of Health, and global partners have published a comprehensive roadmap for development of new STI vaccines.

More Info